In today’s era, monitoring the health of the manufacturing environment has become essential in order to prevent unforeseen repairs, shutdowns, and to be able to detect defective products that could incur big losses. Data-driven techniques and advancements in sensor technology with Internet of the Things (IoT) have made real-time tracking of systems a reality. The health of a product can also be continuously assessed throughout the manufacturing lifecycle by using Quality Control (QC) measures. Quality inspection is one of the critical processes in which the product is evaluated and deemed acceptable or rejected. The visual inspection or final inspection process involves a human operator sensorily examining the product to ascertain its status. However, there are several factors that impact the visual inspection process resulting in an overall inspection accuracy of around 80% in the industry. With the goal of 100% inspection in advanced manufacturing systems, manual visual inspection is both time-consuming and costly. Computer Vision (CV) based algorithms have helped in automating parts of the visual inspection process, but there are still unaddressed challenges. This paper presents an Artificial Intelligence (AI) based approach to the visual inspection process by using Deep Learning (DL). The approach includes a custom Convolutional Neural Network (CNN) for inspection and a computer application that can be deployed on the shop floor to make the inspection process user-friendly. The inspection accuracy for the proposed model is 99.86% on image data of casting products.

Recent advances in manufacturing technology, such as cyber–physical systems, industrial Internet, AI (Artificial Intelligence), and machine learning have driven the evolution of manufacturing architectures into integrated networks of automation devices, services, and enterprises. One of the resulting challenges of this evolution is the increased need for interoperability at different levels of the manufacturing ecosystem. The scope ranges from shop–floor software, devices, and control systems to Internet-based cloud-platforms, providing various services on-demand. Successful implementation of interoperability in smart manufacturing would, thus, result in effective communication and error-prone data-exchange between machines, sensors, actuators, users, systems, and platforms. A significant challenge to this is the architecture and the platforms that are used by machines and software packages. A better understanding of the subject can be achieved by studying industry-specific communication protocols and their respective logical semantics. A review of research conducted in this area is provided in this article to gain perspective on the various dimensions and types of interoperability. This article provides a multi-faceted approach to the research area of interoperability by reviewing key concepts and existing research efforts in the domain, as well as by discussing challenges and solutions.

Background: Type 1 diabetes mellitus (T1DM) is characterized by chronic insulin deficiency and consequent hyperglycemia. Patients with T1DM require long-term exogenous insulin therapy to regulate blood glucose levels and prevent the long-term complications of the disease. Currently, there are no effective algorithms that consider the unique characteristics of T1DM patients to automatically recommend personalized insulin dosage levels.Objective: The objective of this study was to develop and validate a general reinforcement learning (RL) framework for the personalized treatment of T1DM using clinical data.Methods: This research presents a model-free data-driven RL algorithm, namely Q-learning, that recommends insulin doses to regulate the blood glucose level of a T1DM patient, considering his or her state defined by glycated hemoglobin (HbA1c) levels, body mass index, engagement in physical activity, and alcohol usage. In this approach, the RL agent identifies the different states of the patient by exploring the patient’s responses when he or she is subjected to varying insulin doses. On the basis of the result of a treatment action at time step t, the RL agent receives a numeric reward, positive or negative. The reward is calculated as a function of the difference between the actual blood glucose level achieved in response to the insulin dose and the targeted HbA1c level. The RL agent was trained on 10 years of clinical data of patients treated at the Mass General Hospital.Results: A total of 87 patients were included in the training set. The mean age of these patients was 53 years, 59% (51/87) were male, 86% (75/87) were white, and 47% (41/87) were married. The performance of the RL agent was evaluated on 60 test cases. RL agent–recommended insulin dosage interval includes the actual dose prescribed by the physician in 53 out of 60 cases (53/60, 88%).Conclusions: This exploratory study demonstrates that an RL algorithm can be used to recommend personalized insulin doses to achieve adequate glycemic control in patients with T1DM. However, further investigation in a larger sample of patients is needed to confirm these findings.